Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy.
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
PURPOSE: To determine the prevalence and severity of vasomotor, gynecologic, and other symptoms among breast cancer patients, their health concerns, beliefs about estrogen replacement therapy (ERT), and willingness to take estrogen under medical supervision. MATERIALS AND METHODS: A questionnaire was mailed to 320 women aged 40 to 65 years and diagnosed with in situ or invasive locoregional breast cancer in the years 1988 to 1992. RESULTS: Of 222 eligible respondents, 190 were postmenopausal. The prevalence of symptoms among the postmenopausal women was as follows: hot flashes, 65%; night sweats, 44%; vaginal dryness, 48%; dyspareunia, 26%; difficulty sleeping, 44%; and feeling depressed, 44%. The latter two symptoms increased in frequency with increasing severity of vasomotor symptoms (P for trend < or = .001). Forty-one percent of menopausal women perceived that they had experienced, since their breast cancer diagnosis, a physical or emotional problem related to menopause. Of these women, 50% felt they needed treatment. Overall, 31% of postmenopausal women would consider taking estrogen. Those who perceived that they had experienced a menopausal problem were more likely to consider estrogen than those who did not (42% v 22%, P = .003). The proportions willing to take estrogen increased with increasing severity of symptoms, particularly feelings of depression and sleep disturbance (P for trend = .008 and .007, respectively). Awareness that estrogen decreases the risks of heart disease and osteoporosis was not associated with an increased willingness to take it. However, beliefs that estrogen increases the risks of recurrent breast cancer and uterine cancer were associated with a decreased willingness to take it (P = .003 and .08, respectively). CONCLUSION: Vasomotor symptoms have a significant impact on the quality of life of breast cancer patients. Clinical trials to determine the safest and the most effective ways to relieve these symptoms are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 1,997
Bush, T. L., Barrett-Connor, E., Cowan, L. D., Criqui, M. H., Wallace, R. B., Suchindran, C. M., Tyroler, H. A., & Rifkind, B. M. (1987) · Circulation · doi:10.1161/01.cir.75.6.1102 · Cited by 1,346
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R., & Daling, J. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032102 · Cited by 775
Decreased Mortality in Users of Estrogen Replacement Therapy
Henderson, B. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010095012 · Cited by 632
Hot Flashes: Epidemiology and Physiology a
KRONENBERG, F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30316.x · Cited by 601
Megestrol acetate for the prevention of hot flashes.
Loprinzi, C. L., Michalak, J. C., Quella, S. K., O'Fallon, J. R., Hatfield, A. K., Nelimark, R. A., Dose, A. M., Fischer, T., Johnson, C., Klatt, N. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310602 · Cited by 500
Hormonal Treatment of Postmenopausal Women
Wood, A. J. J., & Belchetz, P. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301508 · Cited by 384
Menopausal Estrogen Replacement Therapy and Breast Cancer
Dupont, W. D. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010089011 · Cited by 366
Impact of climacteric on well-being
Oldenhave, A., Jaszmann, L. J. B., Haspels, A. A., & Everaerd, W. T. A. M. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)90817-0 · Cited by 322
Autocrine and paracrine growth regulation of human breast cancer
Lippman, M. E., Dickson, R. B., Bates, S. E., Knabbe, C., Huff, K. K., Swain, S. M., McManaway, M. E., Bronzert, D. A., Kasid, A., & Gelmann, E. P. (1986) · Breast Cancer Research and Treatment · doi:10.1007/bf01806790 · Cited by 305
Prevalence of Genitourinary Symptoms in the Late Menopause
Iosif, C. S., & Bekassy, Z. (1984) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016348409155509 · Cited by 304
Association of Waking Episodes With Menopausal Hot Flushes
Erlik, Y. (1981) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1981.03310420031025 · Cited by 298
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
Goldberg, R. M., Loprinzi, C. L., O'Fallon, J. R., Veeder, M. H., Miser, A. W., Mailliard, J. A., Michalak, J. C., Dose, A. M., Rowland, K. M., & Burnham, N. L. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.155 · Cited by 292
Symptoms Associated With Tamoxifen Treatment in Postmenopausal Women
Love, R. R. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400090120021 · Cited by 273
The South-East England longitudinal study of the climacteric and postmenopause
Hunter, M. (1992) · Maturitas · doi:10.1016/0378-5122(92)90004-n · Cited by 257
Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort
Finucane, F. F. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.1.73 · Cited by 245
A Million Random Digits with 100,000 Normal Deviates.
Kendall, M. G. (1955) · Economica · doi:10.2307/2551199 · Cited by 211
Estrogen replacement therapy. A survey of women's knowledge and attitudes
Ferguson, K. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.1.133 · Cited by 189
SEGALOFF, A. (1966) · Proceedings of the 1965 Laurentian Hormone Conference · doi:10.1016/b978-1-4831-9825-5.50012-9 · Cited by 166
Menopausal hormone replacement therapy and breast cancer: A meta‐analysis
Sillero‐Arenas, M., Delgado‐Rodriquez, M., Rodigues-Canteras, R., Bueno‐Cavanillas, A., & Gálvez-Vargas, R. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90949-j · Cited by 161
An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women
Molander, U., Milsom, I., Ekelund, P., & Mellström, D. (1990) · Maturitas · doi:10.1016/0378-5122(90)90060-j · Cited by 152
Cobleigh, M. (1994) · JAMA · doi:10.1001/jama.272.7.540 · Cited by 152
OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
Rose, D. P., & Davis, T. E. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92716-7 · Cited by 151
The menopause, urinary incontinence and other symptoms of the genito-urinary tract
Rekers, H., Drogendijk, A. C., Valkenburg, H. A., & Riphagen, F. E. (1992) · Maturitas · doi:10.1016/0378-5122(92)90244-x · Cited by 135
The prevalence of hot flash and associated variables among perimenopausal women
Feldman, B. M., Voda, A., & Gronseth, E. (1985) · Research in Nursing & Health · doi:10.1002/nur.4770080308 · Cited by 134
Emotional well-being, sexual behaviour and hormone replacement therapy
Hunter, M. S. (1990) · Maturitas · doi:10.1016/0378-5122(90)90009-u · Cited by 122
Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study
Bergmans, M. G. M., Merkus, J. M. W. M., Corbey, R. S., SCHELLEKENS, L. A., & Ubachs, J. M. H. (1987) · Maturitas · doi:10.1016/0378-5122(87)90005-3 · Cited by 82
Hormone‐replacement therapy in patients with breast cancer: A reappraisal
DiSaia, P. J. (1993) · Cancer · doi:10.1002/cncr.2820710414 · Cited by 56
Estrogen Replacement Therapy in Women with Breast Cancer: A Survey of Patient Attitudes
Vassilopoulou‐Sellin, R., & Zolinski, C. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199209000-00001 · Cited by 55
Vassilopoulou‐Sellin, R., & Theriault, R. L. (1994) · PubMed · Cited by 50
Estrogen-replacement therapy after breast cancer risks versus benefits
Marchant, D. J. (1993) · Cancer · Cited by 36
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Insomnia in the Context of Cancer: A Review of a Neglected Problem
Savard, J., & Morin, C. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.895 · Cited by 861
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., LaVasseur, B. I., Barton, D. L., Novotny, P. J., Dakhil, S. R., Rodger, K., Rummans, T. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03403-6 · Cited by 737
Side Effects of Adjuvant Treatment of Breast Cancer
Shapiro, C. L., & Recht, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442607 · Cited by 724
Metadata
- Authors
- Couzi, R. J., Helzlsouer, K. J., & Fetting, J. H.
- Venue
- Journal of Clinical Oncology
- Published
- 1995-11
- Volume
- 13
- Issue
- 11
- Pages
- 2737-2744
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1934556984
- Cited by
- 315
- References
- 32
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.